US · Healthcare

Aridis Pharmaceuticals Inc (ARDS)

Biotechnology

Aridis Pharmaceuticals Inc (ARDS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ARDS

P/E ratio

18.00

Aridis Pharmaceuticals Inc (ARDS) — FAQ

What is ARDS's P/E ratio?

The price-to-earnings (P/E) ratio for Aridis Pharmaceuticals Inc (ARDS) is 18.00 (data as of 2026-03-23).

Does Aridis Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Aridis Pharmaceuticals Inc (ARDS). Check the MyAverix Finance app for the latest dividend data.

What sector is Aridis Pharmaceuticals Inc in?

Aridis Pharmaceuticals Inc (ARDS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ARDS listed on?

ARDS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)